Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
Current Assets:
Cash and cash equivalents	$ 802.1	$ 617.9
Accounts receivable, less allowance for credit losses	1,452.7	1,363.9
Inventories	2,450.7	2,385.0
Prepaid expenses and other current assets	377.8	357.1
Total Current Assets	5,083.3	4,723.9
Property, plant and equipment, net	2,047.7	2,077.4
Goodwill	9,261.8	9,599.7
Intangible assets, net	7,055.5	7,257.6
Other assets	969.4	980.1
Total Assets	24,417.7	24,638.7
Current Liabilities:
Accounts payable	330.0	400.9
Income taxes payable	59.5	126.7
Other current liabilities	1,667.4	1,413.9
Current portion of long-term debt	500.0	1,500.0
Total Current Liabilities	2,556.9	3,441.5
Deferred income taxes, net	790.4	840.1
Long-term income tax payable	588.1	685.1
Other long-term liabilities	656.4	557.8
Long-term debt	7,626.5	6,721.4
Total Liabilities	12,218.3	12,245.9
Commitments and Contingencies (Note 21)
Stockholders' Equity:
Common stock, $0.01 par value, one billion shares authorized, 311.4 million (309.9 million in 2019) issued	3.1	3.1
Paid-in capital	9,121.6	8,920.1
Retained earnings	10,086.9	10,427.3
Accumulated other comprehensive loss	(297.8)	(241.9)
Treasury stock, 103.8 million shares (103.9 million shares in 2019)	(6,719.6)	(6,720.5)
Total Zimmer Biomet Holdings, Inc. stockholders' equity	12,194.2	12,388.1
Noncontrolling interest	5.2	4.7
Total Stockholders' Equity	12,199.4	12,392.8
Total Liabilities and Stockholders' Equity	$ 24,417.7	$ 24,638.7